Quick Answer
Processa Pharmaceuticals, Inc. reported Gross Profit of $5.0 thousand for fiscal year 2016.
Processa Pharmaceuticals, Inc. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2016 | $5.0K | +140.2% |
| 2015 | -$12.5K | -130.8% |
| 2014 | $40.4K | -67.5% |
| 2013 | $124.5K | +111.4% |
| 2012 | $58.9K | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| March 31, 2016 | $5.0K | -60.9% | -67.8% |
| September 30, 2015 | $15.5K | -43.1% | +72.1% |
| June 30, 2015 | $9.0K | -78.8% | -29.4% |
| March 31, 2015 | $12.8K | +14.2% | -53.2% |
| September 30, 2014 | $27.3K | -39.9% | -35.9% |
| June 30, 2014 | $42.6K | +19.3% | +280.6% |
| March 31, 2014 | $11.2K | +58.4% | -75.4% |
| September 30, 2013 | $45.5K | +200.2% | +27.1% |
- Processa Pharmaceuticals, Inc. showed an increase of +140.2% in Gross Profit compared to the prior fiscal year.
- Over the 2012–2016 period, Processa Pharmaceuticals, Inc.’s gross profit has declined by 91.5% (from $58.9 thousand to $5.0 thousand).
- The most recent figure is from Processa Pharmaceuticals, Inc.’s fiscal year 2016 report (Form 10-K), filed with the SEC on September 25, 2017.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: